[Drug exposure during pregnancy: a differentiated approach].
Numerous drug exposures do occur unintentionally at the beginning of pregnancy. On the other hand, pursuing drug treatment may be necessary in women who wish to be pregnant. In these situations risk evaluation has to be done in a precise and differentiated manner, taking into account at the same time the risk for the fetus and maternal health. Teratovigilance services are able to give a thorough information enabling to avoid unwarranted drug arrests or pregnancy terminations. In return, physician's catamnesis about the outcome of the pregnancy exposed to one or several therapeutic agents will increase the bulk of knowledge health professionals and pregnant women have at their disposal.
Rousso
Ph
P
Swiss Teratogen Information Service (STIS), Division de pharmacologie et toxicologie cliniques, CHUV, Lausanne. philippe.rousso@chuv.hospvd.ch
D000014:Abnormalities, Drug-Induced / Q000209:etiology* / Q000517:prevention & control; D000025:Abortion, Eugenic; D000428:Alcohol Drinking / Q000009:adverse effects*; D001569:Benzodiazepines / Q000627:therapeutic use / Q000633:toxicity; D004358:Drug Therapy; D005260:Female; D063647:Fetal Alcohol Spectrum Disorders / Q000175:diagnosis / Q000517:prevention & control; D006801:Humans; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D011247:Pregnancy; D012306:Risk; D018170:Sumatriptan / Q000627:therapeutic use / Q000633:toxicity
D004364:Pharmaceutical Preparations; D001569:Benzodiazepines; D018170:Sumatriptan